Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
22 NC counties are under alert.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Globus Medical Inc
(NY:
GMED
)
70.44
-1.10 (-1.54%)
Streaming Delayed Price
Updated: 9:46 AM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Globus Medical Inc
< Previous
1
2
3
4
5
6
7
Next >
Globus Medical's Q4 Earnings Beat Estimates, But FY22 Outlook Lags
February 18, 2022
Globus Medical Inc's (NYSE: GMED) Q4 sales rea
Via
Benzinga
Globus Medical: Q4 Earnings Insights
February 17, 2022
Globus Medical (NYSE:GMED) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:15 PM. Here's what investors need to know about the announcement.
Via
Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
February 17, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel...
Via
Benzinga
Earnings Scheduled For February 17, 2022
February 17, 2022
Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million.
Via
Benzinga
Earnings Preview: Globus Medical
February 16, 2022
Globus Medical (NYSE:GMED) is set to give its latest quarterly earnings report on Thursday, 2022-02-17. Here's what investors need to know before the announcement. Analysts estimate that Globus Medical...
Via
Benzinga
FDA Approves Globus Medical's Consolidated Imaging System
August 17, 2021
The
Via
Benzinga
Exposures
Product Safety
Unusual Options Activity Insight: Globus Medical
August 03, 2021
Globus Medical (NYSE:GMED) shares experienced unusual optio...
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...
Via
Benzinga
Exposures
COVID-19
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news...
Via
Benzinga
Why Did BofA Securities Give Globus Medical A Double Upgrade?
December 13, 2021
Enabling tech is likely to continue driving Globus Medical Inc’s (NYSE:
Via
Benzinga
Data Rules All in RYAH Group's IoT Solution for Plant-Based Medicine
December 07, 2021
Photo by Franki Chamaki on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
Were Hedge Funds Right About Hyatt Hotels Corporation?
November 10, 2021
The largest stake in Hyatt Hotels Corporation was held by Melvin Capital Management, which reported holding $283.4 million worth of stock at the end of June.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2022
January 04, 2022
Upgrades According to Vertical Research, the prior rating for Livent Corp (NYSE:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2021
December 13, 2021
Upgrades According to B of A Securities, the prior rating for Globus Medical Inc (NYSE:
Via
Benzinga
Globus Medical (GMED) Q3 2021 Earnings Call Transcript
November 05, 2021
GMED earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Recap: Globus Medical Q3 Earnings
November 04, 2021
Globus Medical (NYSE:GMED) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:15 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
Return on Capital Employed Insights for Globus Medical
August 20, 2021
After pulling data from Benzinga Pro it seems like during Q2, Globus Medical (NYSE:GMED) earned $59.75 million, a 8.98% increase from the preceding quarter. Globus Medical also...
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...
Via
Benzinga
Globus Medical (GMED) Q2 2021 Earnings Call Transcript
August 05, 2021
GMED earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Is Globus Medical's Robotic Surgery Business a Winner?
July 29, 2021
It's still early, but things look promising.
Via
The Motley Fool
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
July 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures
July 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1) Alexion Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
Stocks That Hit 52-Week Highs On Tuesday
July 27, 2021
This morning 85 companies set new 52-week highs. Noteworthy Mentions: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG). Intec...
Via
Benzinga
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
July 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
COVID-19
3 Unstoppable Stocks to Buy and Hold for Years
June 30, 2021
They are in industries where the annual growth rate is 10% or better.
Via
The Motley Fool
Topics
Economy
Exposures
Economy
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
July 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...
Via
Benzinga
Topics
Product Recall
Exposures
COVID-19
Legal
Product Safety
The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout
June 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.